Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOVER: Ranibizumab and PDT for AMD
NCT00680498Phase 4Completed
- Sponsor
- Illinois Retina Associates
- Start
- Feb 2007
- Primary completion
- Jul 2009
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab, verteporfin in age-related macular degeneration (AMD), sponsored by Illinois Retina Associates. Started Feb 2007; status: completed.
02
Drugs
ranibizumabverteporfin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00680498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680498.